Safety and Efficacy Study of NVC-422 on Bacteriuria in Catheterized Patients

Completed · Phase 2

Conditions studied: Asymptomatic Bacteriuria

In brief

The purpose of this clinical trial is to study the effects of NVC-422 instilled into the bladder in reducing bacteria in the urine.

Key facts

Study ID
NCT00781339
Run by
NovaBay Pharmaceuticals, Inc.
People needed
20
Starts
2008-10-01
Expected to finish
2010-03-01
Last updated by the study team
2011-09-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.